https://www.selleckchem.com/pr....oducts/ap-3-a4-enobl
Nearly half the patients developed an infection (8/17) within 3months of sample collection. Infections were mostly clinically diagnosed (62.5%), and the majority involved the respiratory tract (87.5%). We did not detect phenotypic or numerical differences in immune cell populations between patients that did and did not develop infections. Transcriptional profiling of stimulated PBMCs revealed distinct Th2 immune pathway signatures in patients that developed infection. Immune cell counts were not useful predictors of infection r